Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial
Background Major depressive disorder (MDD) is a serious mental health condition. Although pharmacotherapy is the first-line treatment, its use is often limited by side effects and inadequate response. Acupuncture has demonstrated beneficial effects for MDD, and cognitive-behavioral therapy (CBT) is a guideline-recommended psychotherapy. Combining acupuncture with CBT may address both the physiological and psychological aspects of MDD, potentially enhancing therapeutic efficacy. We hypothesize that acupuncture plus CBT will yield superior clinical outcomes compared with antidepressant therapy alone in patients with mild-to-moderate MDD. Methods/design This trial is designed to compare combined acupuncture and CBT with sertraline for mild-to-moderate MDD, using an 8-week treatment period followed by a 16-week follow-up to evaluate clinical efficacy and safety. A total of 104 patients will be enrolled and randomly assigned in a 1:1 ratio to either the acupuncture combined with CBT group or the control group. The primary outcome is the response rate as measured by the 17-item Hamilton Depression Rating Scale (HAMD-17). Secondary outcomes include the remission rate, HAMD-17 scores, Quick Inventory of Depressive Symptomatology–Self-Report (QIDS-SR) scores, Patient Health Questionnaire-15 (PHQ-15) scores, Sheehan Disability Scale (SDS) scores, and performance on the THINC-it tool. Safety will be assessed using Side Effect Rating Scale (SERS) scores. Adverse events (AEs) will be recorded whenever they occur during treatment. Discussion Traditional Chinese medicine (TCM) views the mind and body as an integrated whole and therefore advocates for the concurrent regulation of psychological and somatic processes. Integrating acupuncture with CBT may offer comprehensive benefits for MDD, but high-quality comparative studies against antidepressants are lacking. As an exploratory trial, these findings will provide preliminary evidence to evaluate the role of the combined acupuncture and CBT approach in treating MDD. Clinical trial registration http://Itmctr.Ccebtcm.Org.Cn , identifier ITMCTR2024000653.
Authors
- Wei Lu (ORCID: https://orcid.org/0000-0001-6307-9121)
- Yang Jing (ORCID: https://orcid.org/0009-0002-3090-7511)
- Molin Jiang (ORCID: https://orcid.org/0000-0002-1874-2569)
- Qing-Nan Fu (ORCID: https://orcid.org/0000-0003-1029-4818)
- Jing Hu (ORCID: https://orcid.org/0000-0001-7922-6026)
- Zengqi Man (ORCID: https://orcid.org/0009-0008-9542-9761)
- Hengjia Liu
- Yuxian Wang (ORCID: https://orcid.org/0009-0000-8412-0015)
- Hui Shen
- Yang Li
- Zhengqing Shi
Institutions
- Capital Medical University (CN)
- Community Health Center (US)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fpubh.2026.1925554
- Primary Topic
- Acupuncture Treatment Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00